Q1 2026 Venture Funding Hit $300 Billion — But Strip Out Two Deals and the Story Changes Completely

    $300 billion in one quarter. Crunchbase confirmed the number on April 1, 2026 , and the headlines that followed were predictably breathless: the strongest quarter for global venture since Q2 2022, a figure that topped...

    ByJeff Barnes, MBA
    ·9 min read
    Reviewed by Jeff Barnes — CEO of Angel Investors Network · MBA · $1B+ in Capital Formation
    Q1 2026 Venture Funding Hit $300 Billion — But Strip Out Two Deals and the Story Changes Completely

    $300 billion in one quarter. Crunchbase confirmed the number on April 1, 2026, and the headlines that followed were predictably breathless: the strongest quarter for global venture since Q2 2022, a figure that topped every full-year total prior to 2018, a market back on the ascent. But strip out two deals — one company, really, and its nearest rival — and that number tells a very different story. One that matters considerably more for anyone deploying angel capital in the current environment.

    The Headline Number

    Let's give the bulls their due first. By any conventional measure, Q1 2026 was extraordinary. Crunchbase tracked $300 billion flowing into roughly 6,000 startups globally between January and March, a 150% increase both quarter-over-quarter and year-over-year. That single quarter absorbed approximately 70% of all venture capital deployed across all of 2025. The PitchBook/NVCA Q1 2026 Venture Monitor puts the U.S.-specific figure at $267.2 billion — still enough to top all full-year totals except 2021 and 2025. By any benchmark, that is a genuinely large number.

    The AI sector drove the surge. According to Crunchbase, $242 billion — roughly 80% of total global venture funding — went to AI companies in Q1. That is up from 55% in Q1 2025, itself a record at the time. The full-year 2025 record for AI venture investment was $258 billion. Q1 2026 nearly matched it in 90 days.

    There was also a macro tailwind helping things along. The Federal Reserve held rates steady through the quarter with cuts expected later in the year. The valuation compression that defined 2022 and 2023 has largely worked its way through the system. Investors — particularly in sectors where AI companies trade at 20 to 30 times revenue on public markets — became more willing to underwrite large rounds again. The environment was genuinely more supportive than it had been in several years. That context matters. But it does not explain the shape of what happened.

    The Concentration Problem

    Four of the five largest venture rounds ever recorded were closed in Q1 2026. OpenAI closed a $122 billion round on March 31, valuing the company at $852 billion post-money. The round was anchored by Amazon ($50 billion, with $35 billion conditional on an IPO or AGI milestone), Nvidia ($30 billion), and SoftBank ($30 billion), with co-leads including a16z, D.E. Shaw Ventures, TPG, and T. Rowe Price, plus a broad institutional roster spanning Sequoia, BlackRock, Fidelity, and Temasek. Anthropic raised $30 billion at a $380 billion valuation. xAI pulled in $20 billion, and Waymo closed $16 billion.

    Together, those four deals totaled $188 billion — 65% of all global venture investment in the quarter. Strip them out and the remaining 5,996 funded startups split roughly $112 billion between them. According to CB Insights, even removing only OpenAI's $122 billion round, the quarter still would have registered $163.5 billion — more than any quarter since Q1 2022. That is not nothing. But it is a fundamentally different market than the headline implies.

    CB Insights put it starkly: "This isn't a broad market recovery. It's concentration at the top getting more extreme: fewer bets, later stage, and larger checks." Deal count actually fell 15% quarter-over-quarter in Q1 2026, reaching just under 7,000 deals globally — the lowest quarterly total since Q4 2016 and roughly 61% below the peak set in Q1 2022. That marks four consecutive years of deal count contraction, even as total dollar volume set records.

    PitchBook's data reinforces this picture from a different angle. Exclude the five largest deals and exits in Q1, and the deal value figure falls by 73.2%. "Concentration has defined VC in recent years," the Venture Monitor notes, "but Q1 marked a new extreme."

    The Dakota Q1 Venture Capital Activity Report put median deal size at $14 million for the quarter, up 17% from the prior quarter — but it noted that capital deployed increased at every stage even as deal counts fell. The picture is of investors doing fewer deals but writing larger checks to the ones they commit to. That is a selectivity shift, not a recovery signal.

    What's Happening at Seed and Series A

    Here is where things get complicated for early-stage investors. Crunchbase reported that seed funding was up over 30% year-over-year in Q1 2026, and early-stage funding was up over 40%. On the surface, those are encouraging numbers. Dig one level deeper, and the texture is less straightforward.

    SSTI's analysis — which focuses specifically on deals below $100 million with identified angel and VC investors, filtering out the mega-rounds that distort the headline figures — found that Q1 2026 deal count in that segment came in at 1,486 deals, down from 1,787 in Q4 2025 and dramatically below the 2,721 recorded in Q1 2025. The Q1 2026 figure is less than half that of Q1 2023. SSTI flagged this directly: there was a notable 33% decline in seed-stage deal activity from Q4 2025 to Q1 2026. If Q1 is typically the strongest quarter of the year and this Q1 was the weakest in recent memory at the sub-$100 million level, 2026 could prove a genuinely difficult fundraising environment for most startups.

    At the same time, the TechCrunch reporting noted that seed-stage AI startups are commanding bigger dollars and higher valuations at earlier stages than ever before. So the dollars flowing to seed AI are rising even as overall deal count contracts. For a non-AI seed company, the implication is not subtle: you are competing for attention from a smaller pool of active investors who have more of their focus and capital directed at AI than at any prior point in the data.

    Early-stage deals fell to 64% of total deal count in Q1 2026, down from 68% in Q1 2025. The direction of travel is consistent: capital is gravitating later, toward proven AI infrastructure bets, and away from the exploratory early-stage activity that characterized the 2019–2021 era.

    The Geographic Skew

    The geographic concentration in Q1 2026 is just as pronounced as the deal concentration. Crunchbase data shows U.S.-based companies raised $250 billion — 83% of global venture capital in the quarter. That is up significantly from 71% in Q1 2025, which was itself well above the historical decade average. The logic is straightforward: the four mega-rounds were all U.S.-based companies. Pull them out and the geographic spread would look more normal. Include them and the United States consumed an overwhelming share of all capital deployed globally.

    The second-largest market globally was China at $16.1 billion invested, followed by the U.K. at $7.4 billion. Both were up quarter-over-quarter and year-over-year, which suggests the non-U.S. venture ecosystem is not collapsing — it simply did not benefit from the AI mega-round effect to anywhere near the same degree. Europe, which has been building a credible Series B and C market over the past five years, remains largely outside the blast radius of the AI frontier-lab financing boom. That has implications for where non-AI startups might find capital: European investors, less consumed by AI mega-round dynamics, may offer relatively more runway for companies in other sectors.

    The Honest Assessment for Angel Investors

    Let me be direct about what this data actually means for the people reading this.

    The $300 billion headline is real, and it matters for one reason: it signals that institutional capital has returned to risk-on mode in a meaningful way. The valuation compression of 2022 and 2023 is receding. LPs are committing to new funds — Andreessen Horowitz closed a $15 billion multi-fund raise in Q1. The macro direction is more favorable than it was 18 months ago.

    But angel investors should be clear-eyed about where that capital is actually going, and why the headline may not describe the market in which you are operating. When the top four deals account for 65 cents of every dollar invested in the quarter, the underlying market for everything else looks more like a $112 billion quarter than a $300 billion one. And even that $112 billion is heavily weighted toward late-stage AI infrastructure: semiconductor companies, defense tech, robotics, and compute plays. The number of active investors writing early-stage checks in non-AI sectors was lower in Q1 2026 than in any quarter since 2016.

    For founders pitching outside the AI consensus — whether in healthcare, consumer products, climate technology, or any number of other sectors that drove angel returns in the 2015–2020 era — this is a tighter market than the headline suggests. Not a closed market. Seed activity does exist. But the competition for institutional attention is real, and the investors willing to back non-AI bets at seed are a smaller, more selective group than they were even two years ago.

    There is also the comparison to make explicit. At the 2021 peak, venture euphoria was broadly distributed. Deal counts were at all-time highs. Median round sizes were elevated but not grotesque. Capital was flowing to fintech, edtech, proptech, and a dozen other categories simultaneously. In 2023, the trough was painful but clarifying: only companies with real revenue and credible paths to profitability were getting funded. Q1 2026 is neither of those things. It is something new: a record-setting total produced by a handful of bets on companies that are building what OpenAI's own announcement called "the infrastructure layer for intelligence itself." For everything outside that category, it is closer to 2023 than to 2021 when you look at deal velocity and investor attention.

    What to Watch

    A few signals worth tracking as 2026 unfolds. First, the exit environment. CB Insights reported that global exits hit an almost two-year low in Q1 2026, even as exit value set records — driven by a handful of large transactions including the xAI/SpaceX merger. IPO volume remains subdued. Secondary transactions are increasingly filling the liquidity gap. For angel investors, that means longer expected hold periods and continued pressure on distributions.

    Second, OpenAI's revenue trajectory. Within 28 days of closing the $122 billion round, the Wall Street Journal reported that OpenAI had missed its 2026 revenue targets and fallen short of its goal of one billion weekly active users. The record round and the revenue miss arrived in the same month. If the AI frontier lab thesis begins to show cracks, the ripple effects on the broader AI investment thesis — and on the LP appetite funding the funds writing checks to everything downstream — could be significant.

    Third, defense tech and robotics. These were the most notable non-AI investment themes of Q1 according to the Dakota report, with several billion-dollar rounds closed in both sectors. Institutional investors are directing serious capital toward these areas for the first time at this scale. For angel investors looking for categories where you are not directly competing with the AI consensus trade, these merit attention.

    $300 billion in one quarter. The number is real. But the market it describes is one of the most concentrated, top-heavy, and geographically skewed in the history of venture capital. Understanding the shape of that concentration — not just the headline — is the only way to make sound investment decisions in it.


    The information presented in this article is for informational and educational purposes only and should not be construed as investment advice. Angel Investors Network does not endorse or recommend any specific investment opportunity.

    Investing in startups and early-stage companies involves significant risk, including the potential loss of your entire investment. Past performance is not indicative of future results. Always conduct your own due diligence and consult with a qualified financial advisor before making investment decisions.

    Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.

    Topics

    Related Guides

    Looking for investors?

    Browse our directory of 750+ angel investor groups, VCs, and accelerators across the United States.

    Share
    J

    About the Author

    Jeff Barnes, MBA